Clinical Trial Update: Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating estradiol vaginal tablets for preventing recurrent urinary tract infections in postmenopausal women has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Estradiol vaginal tablet (estradiol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Urinary Infections | Phase 3 | Status: TERMINATED